First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)
Crossref DOI link: https://doi.org/10.1186/s13167-016-0057-3
Published Online: 2016-04-02
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Paltsev, Mikhail
Kiselev, Vsevolod
Drukh, Vadim
Muyzhnek, Ekaterina
Kuznetsov, Igor
Andrianova, Evgeniya
Baranovskiy, Pavel
Funding for this research was provided by:
Ministry of Education and Science of the Russian Federation (RU) (# 02.G25.31.0080 dated from May 23)